403 related articles for article (PubMed ID: 30314283)
1. CEACAM1 in Liver Injury, Metabolic and Immune Regulation.
Horst AK; Najjar SM; Wagener C; Tiegs G
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314283
[TBL] [Abstract][Full Text] [Related]
2. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM
Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571
[TBL] [Abstract][Full Text] [Related]
3. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
[TBL] [Abstract][Full Text] [Related]
4. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.
Zaidi S; Asalla S; Muturi HT; Russo L; Abdolahipour R; Belew GD; Iglesias MB; Feraudo M; Leon L; Kuo E; Liu X; Kumarasamy S; Ghadieh HE; Gatto-Weis C; Zarrinpar A; Duarte S; Najjar SM
Eur J Clin Invest; 2024 Jul; 54(7):e14177. PubMed ID: 38381498
[TBL] [Abstract][Full Text] [Related]
5. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury.
Nakamura K; Kageyama S; Kaldas FM; Hirao H; Ito T; Kadono K; Dery KJ; Kojima H; Gjertson DW; Sosa RA; Kujawski M; Busuttil RW; Reed EF; Kupiec-Weglinski JW
J Clin Invest; 2020 May; 130(5):2689-2704. PubMed ID: 32027621
[TBL] [Abstract][Full Text] [Related]
6. Ceacam1 deletion causes vascular alterations in large vessels.
Najjar SM; Ledford KJ; Abdallah SL; Paus A; Russo L; Kaw MK; Ramakrishnan SK; Muturi HT; Raphael CK; Lester SG; Heinrich G; Pierre SV; Benndorf R; Kleff V; Jaffa AA; Lévy E; Vazquez G; Goldberg IJ; Beauchemin N; Scalia R; Ergün S
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E519-29. PubMed ID: 23800882
[TBL] [Abstract][Full Text] [Related]
7. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Ashkenazi S; Ortenberg R; Besser M; Schachter J; Markel G
Oncotarget; 2016 May; 7(21):30166-77. PubMed ID: 26885752
[TBL] [Abstract][Full Text] [Related]
8. Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease.
Heinrich G; Ghadieh HE; Ghanem SS; Muturi HT; Rezaei K; Al-Share QY; Bowman TA; Zhang D; Garofalo RS; Yin L; Najjar SM
Front Endocrinol (Lausanne); 2017; 8():8. PubMed ID: 28184213
[TBL] [Abstract][Full Text] [Related]
9. CEACAM1 and the regulation of mucosal inflammation.
Nagaishi T; Chen Z; Chen L; Iijima H; Nakajima A; Blumberg RS
Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S39-42. PubMed ID: 19079227
[TBL] [Abstract][Full Text] [Related]
10. Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog.
Kammerer R; Popp T; Härtle S; Singer BB; Zimmermann W
BMC Evol Biol; 2007 Oct; 7():196. PubMed ID: 17945019
[TBL] [Abstract][Full Text] [Related]
11. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Huang YH; Zhu C; Kondo Y; Anderson AC; Gandhi A; Russell A; Dougan SK; Petersen BS; Melum E; Pertel T; Clayton KL; Raab M; Chen Q; Beauchemin N; Yazaki PJ; Pyzik M; Ostrowski MA; Glickman JN; Rudd CE; Ploegh HL; Franke A; Petsko GA; Kuchroo VK; Blumberg RS
Nature; 2015 Jan; 517(7534):386-90. PubMed ID: 25363763
[TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin action by CEACAM1.
Najjar SM
Trends Endocrinol Metab; 2002 Aug; 13(6):240-5. PubMed ID: 12128284
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.
Russo L; Muturi HT; Ghadieh HE; Ghanem SS; Bowman TA; Noh HL; Dagdeviren S; Dogbey GY; Kim JK; Heinrich G; Najjar SM
Diabetologia; 2017 Dec; 60(12):2463-2474. PubMed ID: 28913658
[TBL] [Abstract][Full Text] [Related]
14. Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.
Russo L; Ghadieh HE; Ghanem SS; Al-Share QY; Smiley ZN; Gatto-Weis C; Esakov EL; McInerney MF; Heinrich G; Tong X; Yin L; Najjar SM
J Lipid Res; 2016 Dec; 57(12):2163-2175. PubMed ID: 27777319
[TBL] [Abstract][Full Text] [Related]
15. Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.
Patel PC; Lee HS; Ming AY; Rath A; Deber CM; Yip CM; Rocheleau JV; Gray-Owen SD
J Biol Chem; 2013 Oct; 288(41):29654-69. PubMed ID: 24005674
[TBL] [Abstract][Full Text] [Related]
16. Binding of
Klaile E; Müller MM; Schäfer MR; Clauder AK; Feer S; Heyl KA; Stock M; Klassert TE; Zipfel PF; Singer BB; Slevogt H
mBio; 2017 Mar; 8(2):. PubMed ID: 28292985
[No Abstract] [Full Text] [Related]
17. Age-dependent insulin resistance in male mice with null deletion of the carcinoembryonic antigen-related cell adhesion molecule 2 gene.
Ghanem SS; Muturi HT; DeAngelis AM; Hu J; Kulkarni RN; Heinrich G; Najjar SM
Diabetologia; 2017 Sep; 60(9):1751-1760. PubMed ID: 28567513
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1 regulates insulin clearance in liver.
Poy MN; Yang Y; Rezaei K; Fernström MA; Lee AD; Kido Y; Erickson SK; Najjar SM
Nat Genet; 2002 Mar; 30(3):270-6. PubMed ID: 11850617
[TBL] [Abstract][Full Text] [Related]
19. [CEACAM1 as a central modulator of metabolism, tumor progression, angiogenesis and immunity].
Nouvion AL; Beauchemin N
Med Sci (Paris); 2009 Mar; 25(3):247-52. PubMed ID: 19361387
[TBL] [Abstract][Full Text] [Related]
20. CEACAM1 structure and function in immunity and its therapeutic implications.
Kim WM; Huang YH; Gandhi A; Blumberg RS
Semin Immunol; 2019 Apr; 42():101296. PubMed ID: 31604530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
